topiramate vs tirzepatide as Compared with Semaglutide for the Treatment of Obesity Topiramate vs Semaglutide for Weight

This triple mechanism distinguishes it from existing agents such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GIP/GLP-1 agonist)

doi: 10.1007/s00125-016-3874-y, 37 FeinglosM

Nonalcoholic steatohepatitis is the most common cause of chronic liver disease in the western countries (up to 24% of all patients with liver disease), with 75% of those with NASH being classified as obese (1)

Therapy Monitoring recommendations HgA1c: Measure average blood sugar FBG: Blood glucose concentrations should be monitored closely when ALA supplementation is added to diabetes medication regimens

Your body downregulates thyroid function, reduces non-exercise activity thermogenesis (NEAT), and increases muscle catabolism when caloric restriction becomes too severe